Expert Tips and Cancer Resources

Targeting cancer cells: Two studies take different approaches
A study designed to treat recurrent epithelial ovarian cancer looks at an antibody drug conjugate, and a second study for people with advanced breast cancer evaluates a drug that degrades estrogen rec
The evolution of cancer immunotherapy: Dr. Urba shares his insights
Providence Cancer Institute chief medical officer Walter J. Urba, M.D., Ph.D. talks about the evolution of immunotherapy in the past three decades and his vision for its future.
Cancer survivorship: A guide to living with and beyond cancer
June is National Cancer Survivor Month, but we honor people with cancer, no matter where they are on their journey, every day of the year. Find out about the survivorship program at Providence Cancer
Attend free virtual event on MRI-guided radiation therapy for pancreatic cancer
Providence Cancer Institute presents a free virtual education event about MRI-guided radiation therapy and how it is used to treat pancreatic cancer.
Providence researchers contribute study findings at ASCO 2024 meeting, May 31- June 3
The annual meeting of cancer experts is a platform to collaborate and accelerate cancer research findings into clinical applications.
With the potential to transform cancer diagnostics, Providence contributes to innovative AI-powered digital pathology model
A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model has been published in Nature.
Covenant Health Earns APEx Accreditation for Radiation Oncology Services
The radiation oncology team at Joe Arrington Cancer Center is awarded APEx Accreditation for excellent care.
Cancer studies seek to harness the power of the immune system
Explore three innovative studies targeting uveal melanoma, melanoma and head and neck squamous cell carcinoma. Learn why these studies offer hope for more effective cancer treatments.
Providence Regional Cancer System Patient Navigator Focuses on Head and Neck Cancers
Patient Navigators provide a wealth of information and support to patients and families at all three Providence oncology locations: Lacey, Centralia and Aberdeen.
Providence Swedish advanced lung-cancer technology surpasses 500 patients served
​​​​​​​Ion robot-assisted bronchoscopy and Lung Nodule Clinic continue to ease patients’ way
Celebrating World Immunology Day
Providence Cancer Institute researcher shares her journey to immunology and the advice she has for those seeking a career in cancer research.
Two keys to good men’s health are prevention and detection
Providence Chief Medical Officer Dan Getz, D.O., focuses on prevention for men’s health, as well as early detection of cancer and other illness.
Knowledge is Power
Genetic testing provides insight into inherited health risks.
The Ion Robot: Revolutionizing lung cancer diagnostics
Precision technology empowers early detection for improved patient outcomes
New vaccine being studied for HPV+ head and neck cancer
Researchers at Providence Cancer Institute are exploring a range of innovative approaches to targeting human papillomavirus-positive head and neck squamous cell cancer.
Synergy at the Advanced Care Center
With five specialty practices under one roof, patients experience optimal care with maximum convenience at the Providence Advanced Care Center.
Celebrating our oncology social workers
In recognition of National Social Work Month, Darlene Corral, LCSW, shares a little insight into the importance of oncology social workers.
Providence Alaska to host colorectal cancer awareness event March 26
The Providence Cancer Center is hosting an event to help raise awareness about colorectal cancer 11 a.m.-1 p.m. Tuesday, March 26, in the Providence Health Park.
Talking to an expert: The crucial role of nutrition in cancer care
In honor of National Nutrition Month® Alyssa George, MA, RDN, program manager at Oncology Nutrition, Providence Cancer Institute, talks about the important connection between cancer and nutrition.
How promoting apoptosis in new study may help people with cancer
In a new clinical trial open at Providence Cancer Institute, the therapy IGM-8444 aims to promote apoptosis, potentially slowing down the growth of DR5-positive tumor cells.
Dose-escalation studies aspire to fill gaps in cancer treatment options
Two early phase trials available at Providence Cancer Institute to evaluate escalating doses of different potential cancer treatments in patients with advanced solid tumors.
FDA approves cellular therapy, offering hope to more people with cancer
The Food and Drug Administration has approved an adoptive cell therapy for adult patients with melanoma that has spread to other parts of the body (metastatic).
Gateway Food Pantry provides meals and hope to those in need
Supporting thousands of patients experiencing food insecurity, a converted space at Providence Gateway Internal Medicine clinic is filled with fresh fruits and vegetables, meat, milk, eggs and more.
Leading the Way in Early Cancer Detection
​​​​​​​Providence Saint Joseph Medical Center has opened a Multi-Cancer Early Detection Clinic, the first of its kind in the San Fernando Valley.
Providence oncology nurse practitioner receives Values in Action Award
Jamie Zilverberg, MSN, FNP, AOCNP, receives the prestigious 2024 Values in Action Award, the highest honor given at Providence St. Joseph Health.
Innovating cancer care: A new and improved approach to lung cancer treatment
The Ion Robotic Bronchoscopy System, a new surgical technology, is improving early screening, detection and treatment of lung cancer – which means a better chance of survival.
Celebrating Women in Science
In honor of International Day of Women and Girls in Science we highlight a researcher at Earle A. Chiles Research Institute, the research arm of Providence Cancer Institute.
Virtual education: Food and common cancer myths
Providence registered dietitian Christina Speaks, MS, RDN, LD, shares valuable information about food and common cancer myths.
Studies address need for more treatment options in endometrial cancer and AML
New study evaluates immunotherapy in combination with other medications in people with endometrial cancer, and a phase I trial for people with AML assesses a non-engineered natural killer cell therapy
Side by Side
Twin sisters Kerrie and Kristine face breast cancer and a genetic risk of stomach cancer together.